Location: Hellerup, Denmark
CIK: 0001388325 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value: $695M (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,979,100 | $286M | 41.1% | $95.92 | $57.39 | — | TOTAL STK MKT | 922908769 |
| — | OPHTHOTECH CORP | 6,910,489 | $224M | 32.2% | $32.35 | $32.35 | — | COM | 683745103 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $124M | 17.8% | $58.80 | $45.01 | — | FTSE EUROPE ETF | 922042874 |
| — | WRIGHT MED GROUP INC | 585,759 | $17.99M | 2.6% | $30.71 | $23.81 | — | COM | 98235T107 |
| — | TETRAPHASE PHARMACEUTICALS INC | 1,200,000 | $16.22M | 2.3% | $13.52 | $13.52 | — | COM | 88164N105 |
| — | TETRAPHASE PHARMACEUTICALS INC | 1,200,000 | $16.22M | 2.3% | $13.52 | $13.52 | — | COM | 88165N105 |
| PTCT | PTC THERAPEUTICS INC | 597,359 | $10.14M | 1.5% | $16.97 * | $17.38 | +1.1% | COM | 69366J200 |
| — | WRIGHT MED GROUP INC | 4,720,065 | $1.525M | 0.2% | $0.32 | $2.50 | — | RIGHT 03/01/2019 | 98235T115 |